Screening and associations to cervical câncer
DOI:
https://doi.org/10.5712/rbmfc16(43)2992Keywords:
Ginecology, Uterine Cervical Dysplasia, Comprehensive Health Care, Moral Risk in Supplementary Health Insurance;, Public Health Administration.Abstract
Introduction: According to the National Cancer Institute (INCA) the estimate of new cases of cervical cancer (CC) for the State of Espírito Santo in the 2020-2022 period is 11.65 per 100,000 inhabitants. Objective: To trace the clinical-epidemiological profile of users of the Comprehensive Women's Health Care Service at the XXXXXXXXXX (XXX), based on the determinants of gynecological consultation, and correlate with cytological and histological findings. Methods: Cross-sectional, observational and retrospective study involving 590 medical records of patients, attended between February 2011 and July 2016 at the Comprehensive Care Service for Women's Health in the Polyclinic / XXXXXXXXXX. Results: The average age of women included in this study was 39.5 years (SD ± 16.2). Risk factors such as marital status and length of marital relationship, multiparity, and use of oral hormonal contraceptives were associated with an increased chance of CC. Statistical association of the age variable did not show a risk of CC. Conclusion: The results are in line with those recommended by INCA and the Ministry of Health. This reinforces the importance of traceability in primary care and the factors that interfere with it.
Downloads
Metrics
References
(1) International Agency of Research on Cancer (IARC). ICO/IARC Information Centre on HPV and Cancer. Brazil human papillomavirus and related cancers, fact sheet [Internet]. Lyon: IARC; 2019; [acesso em ANO Jun 17]. Disponível em: https://hpvcentre.net/statistics/reports/BRA_FS.pdf
(2) Instituto Nacional de Câncer José Alencar Gomes Da Silva (INCA). Parâmetros técnicos para o rastreamento do câncer do colo do útero [Internet]. Rio de Janeiro (RJ): INCA; 2019. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//parametros_tecnicos_colo_do_utero_2019.pdf
(3) Haverkos HW, Haverkos GP, O’Mara M. Co-carcinogenesis: human papillomaviruses, coal tar derivatives, and squamous cell cervical cancer. Front Microbiol. 2017 Out;8:2253. DOI: https://doi.org/10.3389/fmicb.2017.02253
(4) Nakagawa JTT, Schirmer J, Barbieri M. Vírus HPV e câncer de colo de útero. Rev Bras Enferm. 2010;63(2):307-11.
(5) Anttila A, Von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer. 2009 Oct;45(15):2649-58. DOI: https://doi.org/10.1016/j.ejca.2009.07.020
(6) Instituto Nacional de Câncer José Alencar Gomes Da Silva (INCA). Diretrizes brasileiras para o rastreamento do câncer do colo do útero [Internet]. Rio de Janeiro (RJ): INCA; 2016. Disponível em: http://www1.inca.gov.br/estimativa/2018/estimativa-2018.pdf
(7) Melo SCC, Prates L, Carvalho MDB, Marcon SS, Pelloso SM. Alterações citopatológicas e fatores de risco para a ocorrência do câncer de colo uterino. Rev Gaúcha Enferm Online. 2009 Dez;30(4):602-8. DOI: https://doi.org/10.1590/S1983-14472009000400004
(8) Silva ML, Nunes JSS, Oliveira KS, Leite TAS. Conhecimento de mulheres sobre câncer de colo do útero: uma revisão integrativa. Braz J Health Rev. 2020;3(4):7263-75. DOI: https://doi.org/10.34119/bjhrv3n4-005
(9) Palefsky JM, Hirsch MS, Bloom A. Human papillomavirus infections: epidemiology and disease associations [Internet]. Waltham: UpToDate; 2018. Disponível em: https://www.uptodate.com/contents/human-papillomavirus-infections-epidemiology-and-disease-associations
(10) International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomark Prev. 2009 Apr;18(4):1060-9. DOI: https://doi.org/10.1158/1055-9965.EPI-08-1186
(11) International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007 Nov;370(9599):1609-21. DOI: https://doi.org/10.1016/S0140-6736(07)61684-5
(12) Lemos ARM, Silva MS, Segati KD. Lesão de alto grau e carcinoma escamoso: um estudo de prevalências em pacientes atendidas pelo Sistema Único de Saúde (SUS) na cidade de Anápolis, GO, Brasil. RBAC. 2017;49(2):152-7. DOI: https://doi.org/10.21877/2448-3877.201600494
(13) Alves JF, Oliveira WLS, Mendonça BOM, Oliveira VCC, Nogueira DS, Barros EJ, et al. Exame colpocitológico (papanicolau): O conhecimento das mulheres sobre o preventivo no combate do câncer de colo do útero. Rev Faculdade Montes Belos (FMB). 2016; [citado ANO Mês dia]; 9(2):125-41. Disponível em: http://revista.fmb.edu.br/index.php/fmb/article/view/228/205
(14) Lima WF, Barbosa SLF, Oliveira GAL. Profile of gynecological cytopathology exams carried out in a north Piauí clinic: documental analysis. Res Soc Dev. 2020;9(7):e325974440. DOI: https://doi.org/10.33448/rsd-v9i7.4440
(15) Silva RCG, Silva ACO, Peres AL, Oliveira SR. Perfil de mulheres com câncer de colo do útero atendidas para tratamento em centro de oncologia. Rev Bras Saude Mater Infant. 2018 Out/Dez;18(4):695-702. DOI: https://doi.org/10.1590/1806-93042018000400002
(16) Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002 Mar;359(9312):1093-101. DOI: https://doi.org/10.1016/S0140-6736(02)08151-5
(17) Smith JS, Green J, Gonzalez AB, Appebly P, Peto J, Plummer M, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003 Apr;361(9364):1159-67. DOI: https://doi.org/10.1016/s0140-6736(03)12949-2
(18) Uchimura NS, Ribalta JCL, Focchi J, Baracat EC, Uchimura TT. Influência do uso de anticoncepcionais hormonais orais sobre o número de células de Langerhans em mulheres com captura híbrida negativa para papilomavírus humano. Rev Bras Ginecol Obstet. 2005 Dez;27(12):726-30. DOI: https://doi.org/10.1590/S0100-72032005001200004
(19) Monteiro DLM, Trajano AJB, Silva KS, Russomano FB. Pre-invasive cervical disease and uterine cervical cancer in Brazilian adolescents: prevalence and related factors. Cad Saúde Pública. 2006 Dez;22(12):2439-48. DOI: https://doi.org/10.1590/S0102-311X2006001200004
(20) Oliveira GR, Vieira VC, Barral MFM, Döwich V, Soares MA, Conçalves CV, et al. Fatores de risco e prevalência da infecção pelo HPV em pacientes de Unidades Básicas de Saúde e de um Hospital Universitário do Sul do Brasil. Rev Bras Ginecol Obstet. 2013 Mai;35(5):226-32. DOI: https://doi.org/10.1590/S0100-72032013000500007
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Amine Selim de Salles Gonçalves Melado, Icaro Borges de Oliveira, Filipe Alvarenga Caetano Vitorino, Janinne Fachetti Rocha, Gustavo Enrico Cabral Ruschi, Waleska Souza Reisman, Ana Rosa Murad Szpilman
This work is licensed under a Creative Commons Attribution 4.0 International License.
By submitting a manuscript to the RBMFC, authors retain ownership of the copyright in the article, and authorize RBMFC to publish that manuscript under the Creative Commons Attribution 4.0 license and identify itself as the vehicle of its original publication.
